Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-guided integration of aging-related functional assessment to predict nonresponse to cardiac rehabilitation in heart failure.

The journal of nutrition, health & aging·2026
Same author

Transcriptome fingerprinting of aberrant fibroblast activation unlocks effective therapeutics to tackle cardiac fibrosis.

Science advances·2025
Same author

Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis.

Cell death & disease·2025
Same author

Galanin Coordinates Macrophage-Associated Fibro-Inflammatory Response and Mitochondrial Integrity in Myocardial Infarction Reperfusion Injury.

International journal of molecular sciences·2024
Same author

Age-Related Shift in Cardiac and Metabolic Phenotyping Linked to Inflammatory Cytokines and Antioxidant Status in Mice.

International journal of molecular sciences·2023
Same author

Correction: IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.

Biology direct·2023

Related Experiment Video

Updated: Jun 28, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

689

Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.

Verena Poinsot1, Nathalie Pizzinat1, Varravaddheay Ong-Meang1

  • 1Inserm, CNRS, Faculté de Santé, Université Toulouse III-Paul Sabatier, I2MC U1297, 31432 Toulouse, France.

Nanomaterials (Basel, Switzerland)
|April 12, 2024
PubMed
Summary

Exosomes, natural nanovesicles, show promise for drug delivery. Hemisynthetic approaches and exosome-mimes offer solutions to challenges in using these extracellular vesicles (EVs) therapeutically.

Keywords:
drug deliveryexosome-mimeexosomesextracellular vesicleshybrid exosome

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.2K

Related Experiment Videos

Last Updated: Jun 28, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

689
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.2K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cell Biology

Background:

  • Exosomes are nanovesicles derived from endosomes, crucial for intercellular communication.
  • These extracellular vesicles (EVs) transport cellular contents, including nucleic acids and proteins, to recipient cells.
  • Their natural targeting ability makes exosomes attractive for drug delivery applications.

Purpose of the Study:

  • To explore the therapeutic potential of exosomes as drug delivery systems.
  • To address challenges associated with the clinical application of exosomes.
  • To review alternative exosome-based nanocarriers and their drug-loading strategies.

Main Methods:

  • Review of exosome biogenesis and function.
  • Analysis of hemisynthetic approaches, including cell-membrane coatings and exosome-liposome hybrids.
  • Summary of drug-loading techniques for exosome-based carriers.
  • Compilation of data from ongoing clinical trials involving exosomes.

Main Results:

  • Exosomes can encapsulate and deliver therapeutic payloads to target cells.
  • Hemisynthetic strategies and exosome-mimes offer viable alternatives to overcome limitations of natural exosomes.
  • Various drug-loading methods are being developed to enhance therapeutic efficacy.
  • Clinical trials are underway to evaluate the safety and efficacy of exosome-based therapies.

Conclusions:

  • Exosomes and exosome-like structures hold significant potential for targeted drug delivery.
  • Further research is needed to optimize exosome-based systems for reliable therapeutic applications.
  • Addressing current challenges is crucial for the successful clinical translation of exosome-based therapeutics.